Invention Publication
- Patent Title: BICYCLIC AMINES AS CDK2 INHIBITORS
-
Application No.: US18064080Application Date: 2022-12-09
-
Publication No.: US20230183250A1Publication Date: 2023-06-15
- Inventor: Joshua Hummel , David M. Burns , Ding-Quan Qian , Xiaozhao Wang
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Main IPC: C07D487/04
- IPC: C07D487/04
Abstract:
The present application provides bicyclic amines of Formula (I):
and their pharmaceutically acceptable salts thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
and their pharmaceutically acceptable salts thereof, that are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Public/Granted literature
- US11976073B2 Bicyclic amines as CDK2 inhibitors Public/Granted day:2024-05-07
Information query
